Everhart A - Search Results

1

Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial.

Vu K, Zhou J, Everhart A, Desai N, Herrin J, Jena AB, Ross JS, Shah ND, Karaca-Mandic P. Vu K, et al. Among authors: everhart a. BMC Nephrol. 2021 Aug 21;22(1):284. doi: 10.1186/s12882-021-02491-y. BMC Nephrol. 2021. PMID: 34419007 Free PMC article.

2

Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm.

Smith LB, Desai NR, Dowd B, Everhart A, Herrin J, Higuera L, Jeffery MM, Jena AB, Ross JS, Shah ND, Karaca-Mandic P. Smith LB, et al. Among authors: everhart a. Int J Health Econ Manag. 2020 Sep;20(3):299-317. doi: 10.1007/s10754-020-09282-2. Epub 2020 Apr 30. Int J Health Econ Manag. 2020. PMID: 32350680 Free PMC article.

3

Physician variation in the de-adoption of ineffective statin and fibrate therapy.

Everhart A, Desai NR, Dowd B, Herrin J, Higuera L, Jeffery MM, Jena AB, Ross JS, Shah ND, Smith LB, Karaca-Mandic P. Everhart A, et al. Health Serv Res. 2021 Oct;56(5):919-931. doi: 10.1111/1475-6773.13630. Epub 2021 Feb 10. Health Serv Res. 2021. PMID: 33569804 Free PMC article.

4

Physician Network Connections Associated With Faster De-Adoption of Dronedarone for Permanent Atrial Fibrillation.

Stecher C, Everhart A, Smith LB, Jena A, Ross JS, Desai NR, Shah N, Karaca-Mandic P. Stecher C, et al. Among authors: everhart a. Circ Cardiovasc Qual Outcomes. 2021 Oct;14(10):e008040. doi: 10.1161/CIRCOUTCOMES.121.008040. Epub 2021 Sep 24. Circ Cardiovasc Qual Outcomes. 2021. PMID: 34555928 Free PMC article.

5

Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage.

Everhart A, Harper K, Jeffery MM, Levin Z, Morden NE, Sankar A, Karaca-Mandic P. Everhart A, et al. JAMA Netw Open. 2021 Sep 1;4(9):e2127349. doi: 10.1001/jamanetworkopen.2021.27349. JAMA Netw Open. 2021. PMID: 34586370 Free PMC article.

6

Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance.

Everhart AO, Sen S, Stern AD, Zhu Y, Karaca-Mandic P. Everhart AO, et al. JAMA. 2023 Jan 10;329(2):144-156. doi: 10.1001/jama.2022.22974. JAMA. 2023. PMID: 36625811 Free PMC article.

7

Longitudinal Patterns in Testosterone Prescribing After US FDA Safety Communication in 2014.

Sankar A, Everhart AO, Jena AB, Jeffery MM, Ross JS, Shah ND, Karaca-Mandic P. Sankar A, et al. Among authors: everhart ao. Jt Comm J Qual Patient Saf. 2023 Sep;49(9):458-466. doi: 10.1016/j.jcjq.2023.05.003. Epub 2023 May 24. Jt Comm J Qual Patient Saf. 2023. PMID: 37380503

8

Measuring Primary Care Exam Length Using Electronic Health Record Data.

Neprash HT, Everhart A, McAlpine D, Smith LB, Sheridan B, Cross DA. Neprash HT, et al. Among authors: everhart a. Med Care. 2021 Jan;59(1):62-66. doi: 10.1097/MLR.0000000000001450. Med Care. 2021. PMID: 33301282

9

Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance-Reply.

Everhart AO, Zhu Y, Stern AD. Everhart AO, et al. JAMA. 2023 May 9;329(18):1609-1610. doi: 10.1001/jama.2023.4095. JAMA. 2023. PMID: 37159037 No abstract available.

10

Time to publication of cost-effectiveness analyses for medical devices.

Everhart AO. Everhart AO. Am J Manag Care. 2023 May;29(5):265-268. doi: 10.37765/ajmc.2023.89359. Am J Manag Care. 2023. PMID: 37229785 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page